We do not earn a commission from this provider.
LumiMeds review
Graded on whether a price is published, checkable, and still true at month two — how we grade · how we verify prices
LumiMeds advertises semaglutide as low as $89 a month and tirzepatide as low as $125. Ninety-five steps through its own intake produced no price at all.
- No month-to-month price published
- States not published
- Prices read September 2026
Read first-hand, not from a feed.
Distinct plans priced.
This link pays us nothing. It's here because the price is checkable.
The verdict
Every figure on this site is a floor. The plans page announces monthly, three, six and twelve month options in capital letters and then prices none of them.
This link pays us nothing. It's here because the price is checkable.
Quick facts
Key facts
- Semaglutide
- As low as $89 a month
- Tirzepatide
- As low as $125 a month
- NAD+
- As low as $119 a month
- Plan prices
- None published on any page we read
- Intake
- Walked 95 steps with dummy data, no price shown
- States served
- Not published on any page we read
Pros and cons
What we like
- The plans page is a real catalog — three products, each with a form, a cadence and a floor price in one comparison table.
- The terms name the operating company and the separate telehealth group whose clinicians write the prescriptions.
- The pages are explicit that compounded drugs are not FDA-approved and that eligibility is a clinician's decision.
What could be better
- Every price on the site is an as-low-as floor, including the ones in the comparison table headed Starts at.
- The page announces four plan lengths in capitals and prices none of them.
- Ninety-five steps of intake with dummy data produced no plan table, so the real number is not reachable without committing.
What it is
A weight-loss and longevity platform with three products: compounded semaglutide, compounded tirzepatide and an injectable NAD+ program. Clinician review is promised inside five hours, there is no membership, and the terms name both the operating company and the telehealth group behind the prescribers.
Every price we found
| Plan | Advertised | What you actually pay | The gap | Read on |
|---|---|---|---|---|
| Compounded semaglutide, published floorAn as-low-as figure. Monthly, three, six and twelve month options are named but not priced. | $89 | not published | not comparable | September 2026 |
| Compounded tirzepatide, published floorAn as-low-as figure, on the same terms as the semaglutide plan. | $125 | not published | not comparable | September 2026 |
| NAD+, published floorAn as-low-as figure for the weekly injectable longevity plan. | $119 | not published | not comparable | September 2026 |
This link pays us nothing. It's here because the price is checkable.
What it actually costs
The plans page gives three as-low-as figures — $89 for semaglutide, $125 for tirzepatide, $119 for NAD+ — and repeats them in a comparison table under the heading Starts at. The product pages carry the same three floors and nothing else.
The semaglutide page states in capitals that monthly, three, six and twelve month options are available. It does not price any of them. Neither does the tirzepatide page, the NAD+ page or the plans page.
We walked the eligibility assessment ninety-five steps with dummy data and stopped short of any payment step. No plan table appeared. So what month two costs is unpublished rather than merely buried — a floor without a ladder.
Who it's wrong for
- Skip it if you want to compare on price. Three floors and no plan prices give you nothing to compare with.
- Skip it if you will not hand over health answers before seeing a number — the assessment is the only path we found toward one.
- Skip it if you need a state list. None appears on the plans page or the product pages.
- Same product, priced properly: Lumen Meds charges $114.99 a month for semaglutide.
Is LumiMeds legit?
LumiMeds is operated by Luminate Ventures LLC d/b/a Lumimeds. We read that off the company’s own terms of use on September 2026.
Common questions
What does LumiMeds charge for a single month?
No page we read prices a single month. The site publishes as-low-as floors of $89, $125 and $119, and names monthly and multi-month options without pricing them.
Can the price be found by starting the assessment?
Not in ninety-five steps. We walked the eligibility assessment with dummy data, entered no payment details, and reached no plan table or checkout figure.
Why we gave LumiMeds a F
Read the full grading rationale
Every figure on this site is a floor. The plans page prints as-low-as rates of $89 for semaglutide, $125 for tirzepatide and $119 for NAD+, states in capitals that monthly, three, six and twelve month options are available, and then prices none of them. The product pages repeat the same three floors and add nothing. Ninety-five steps through the eligibility assessment with dummy data produced no price at any point; the flow returned to its own first screen rather than reaching a plan table. So the one number that decides whether this is cheap or expensive — what month two costs — is not published on any page we read and was not reachable by walking the intake. The terms name the operating company and the telehealth group behind it.
How we reviewed LumiMeds
- Read the plans page and both GLP-1 product pages first-hand on 2026-09-03, then walked the eligibility assessment with dummy data.
- The walk was stopped well before any payment step, and the absence of a price is reported with the step count attached.
The page we read — all on
- Products page
Semaglutide GLP-1 Appetite control & steady weight loss Weekly injection $89/mo
This link pays us nothing. It's here because the price is checkable.
Alternatives to LumiMeds
| Provider | Grade | Cheapest price |
|---|---|---|
| Harbor | CCaveat | $89/mo |
| Invyncible | CCaveat | $88/mo |
| Mint Med | AVerified | $86/mo |
| CoreAge Rx | CCaveat | $93/mo |
| TRT Nation | CCaveat | $80/mo |